Deloitte is reducing certain healthcare benefits for US employees from January 2027, including ending medical-plan coverage for GLP-1 medications prescribed for weight loss.
According to an internal benefits guide obtained by Business Insider, the firm will also increase deductibles and out-of-pocket maximums under most health insurance plans.
The changes apply to employees Deloitte classifies as Core, Domain and Enterprise professionals, a group that includes most of its traditional client-facing accountants, consultants and technical specialists.
Deloitte employs approximately 181,000 people in the United States.
What is changing?
The benefits guide outlines several changes:
Weight-loss medications: Deloitte will no longer cover GLP-1 drugs prescribed for weight loss. Coverage will continue when the medications are prescribed for diabetes and other covered medical conditions.
Health insurance costs: Deductibles and out-of-pocket maximums will increase under most plans.
Alternative weight-loss support: Employees will have access to eMed, a virtual lifestyle programme offering coaching and a $125 employer contribution per prescription.
Long-term disability: Deloitte is improving its long-term disability protection.
Vision care: The firm is adding free annual eye examinations to its company-paid discount vision programme.
Deloitte cites rising healthcare costs
A Deloitte spokesperson told Business Insider that the firm had made selected modifications where healthcare cost increases were no longer sustainable.
The spokesperson said the new weight-management support would include access to medication at direct-from-manufacturer prices.
Deloitte also said its overall financial commitment to employees and their families continued to grow.
The latest changes follow earlier reductions to employee benefits affecting a separate group of US staff.
Business Insider reported in April that employees in Deloitte’s Center talent model, which largely covers internal administrative roles, would see certain parental leave, paid time off and IVF benefits reduced or eliminated from 1 January 2027.
The article also reported that PwC had restricted coverage for GLP-1 medications prescribed for weight loss during 2026.
Related reading
Deloitte Offers Parental Leave. A Lawsuit Alleges Employees Who Take It Are Penalised — A proposed class action concerning the treatment of Deloitte US employees who take protected leave.
Burnout, Long Hours and the Big Four People Model — Former Deloitte Malta HR manager Mikela Fenech Pace discusses workplace culture, employee wellbeing and career progression.
Want to stay up to date on all things Big Four around the world?
Check out the News section and subscribe to Big4News for weekly deep dives and briefings.
About the author: Claudine Cassar is the founder and editor of Big4News, covering audit, consulting, regulation and governance across Deloitte, PwC, EY and KPMG.



